- Home
- HELP vs HSTM Comparison
HELP vs HSTM Comparison
Compare HELP & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HELP | HSTM |
|---|---|---|
| Founded | N/A | 1990 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 854.9M | 943.0M |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | HELP | HSTM |
|---|---|---|
| Price | $11.95 | $33.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $40.12 | $34.50 |
| AVG Volume (30 Days) | ★ 1.6M | 152.4K |
| Earning Date | 11-12-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 0.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $304,064,000.00 |
| Revenue This Year | N/A | $8.31 |
| Revenue Next Year | N/A | $4.59 |
| P/E Ratio | ★ N/A | $75.51 |
| Revenue Growth | N/A | ★ 4.26 |
| 52 Week Low | $3.76 | $19.50 |
| 52 Week High | $15.15 | $32.50 |
Technical Indicators
Market Signals| Indicator | HELP | HSTM |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 79.93 |
| Support Level | $11.26 | $27.77 |
| Resistance Level | $14.35 | N/A |
| Average True Range (ATR) | 0.69 | 0.71 |
| MACD | -0.25 | 0.35 |
| Stochastic Oscillator | 43.46 | 99.02 |
Price Performance
Historical ComparisonAbout HELP Cybin Inc. Common Stock
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
About HSTM HealthStream Inc.
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.